| 前收市價 | 0.5000 |
| 開市 | 0.5000 |
| 買盤 | 0.1500 |
| 賣出價 | 1.5500 |
| 拍板 | 180.00 |
| 到期日 | 2024-06-21 |
| 今日波幅 | 0.5000 - 0.5000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 1 |
- Reuters
Becton Dickinson lifts profit view on strong surgical equipment demand
Becton Dickinson raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical equipment and syringes. Medical technology firms like Becton, Boston Scientific and Abbott Laboratories are benefiting from a boost in demand as more people, especially older patients, undergo surgeries that were put on hold during the pandemic. The company's biggest unit, which makes devices to administer drugs, reported quarterly sales of $2.45 billion, in line with analysts' expectations, according to LSEG data.
ZacksWhat's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Here is a sneak peek into how five medical device stocks, BDX, BAX, XRAY, CAH and DVA, might fare in their quarterly results slated to be released tomorrow.
ZacksSustained Product Demand Likely to Aid BD's (BDX) Q2 Earnings
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
